UJ9.F SHANDONG BOAN BIOTECH.H 1

Healthcare Biotechnology Frankfurt Exchange
0.3460 EUR
Close of Nov 12, 2026
0.2700 1.16
Market cap
EUR 212M
P/E
-
P/B
0.60x
ROE
0.3%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the fiscal year ending Dec 2025.

Is UJ9.F undervalued?

Graham number

The Graham number of SHANDONG BOAN BIOTECH.H 1 cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

SHANDONG BOAN BIOTECH.H 1 fundamental analysis

No fundamental analysis for SHANDONG BOAN BIOTECH.H 1 yet.

SHANDONG BOAN BIOTECH.H 1 stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About SHANDONG BOAN BIOTECH.H 1

Shandong Boan Biotechnology Co., Ltd., a biopharmaceutical company, develops, manufactures, and markets biologics in Mainland China. The company offers Boyounuo (BA1101), an anti-VEGF humanized monoclonal antibody injection for mCRC, advanced metastatic or recurrent non-small cell lung cancer, recurrent glioblastoma, epithelial ovarian, fallopian tube, primary peritoneal cancer, cervical cancer, and hepatocellular carcinoma indications; Boyoubei (BA6101), a human immunoglobu…

Full company profile